Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma's Global Platform is drawing significant interest across the industry.
NEW YORK, March 3, 2026 /PRNewswire/ -- Royalty Pharma plc (Nasdaq: RPRX) announced the appointment of Kenneth Sun as Senior Vice President and Head of Asia, effective May 2026. Ken will be based in Hong Kong and lead the company's royalty business in Asia. Ken joins Royalty Pharma from Morgan Stanley, where he was Head of Asia Pacific Healthcare Investment Banking.
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- Mayor Sadiq Khan invites embattled AI firm Anthropic to expand in London
- Missoula mayor heads to New Zealand for diplomacy trip
- T. rex took 40 years to reach full size, study finds
- Strength In Every Stride: Nearly 750 Women Run For Empowerment At KDMC's 'Runaragini Marathon' In Kalyan
Source: Original →